The U.S. recently backed out of the United Nation's HIV/AIDS program and froze billions in foreign HIV-prevention efforts.

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Older adults with HIV are at significantly higher risk for cutaneous malignancies when compared with younger patients with HIV.

The House of Representatives narrowly passed a budget resolution, which Malliotakis voted in favor of, late last month.